144 related articles for article (PubMed ID: 32154716)
1. Simultaneous Analysis of Multiple Cancer Biomarkers Using MALDI-TOF Mass Spectrometry Based on a Parylene-Matrix Chip.
Park JM; Kim MJ; Noh JY; Yun TG; Kang MJ; Lee SG; Yoo BC; Pyun JC
J Am Soc Mass Spectrom; 2020 Apr; 31(4):917-926. PubMed ID: 32154716
[TBL] [Abstract][Full Text] [Related]
2. MALDI-TOF Mass Spectrometry Based on Parylene-Matrix Chip for the Analysis of Lysophosphatidylcholine in Sepsis Patient Sera.
Park JM; Noh JY; Kim MJ; Yun TG; Lee SG; Chung KS; Lee EH; Shin MH; Ku NS; Yoon S; Kang MJ; Park MS; Pyun JC
Anal Chem; 2019 Nov; 91(22):14719-14727. PubMed ID: 31621295
[TBL] [Abstract][Full Text] [Related]
3. Parylene-matrix chip for small molecule analysis using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Kim JI; Park JM; Kang MJ; Pyun JC
Rapid Commun Mass Spectrom; 2014 Feb; 28(3):274-80. PubMed ID: 24375878
[TBL] [Abstract][Full Text] [Related]
4. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of small volatile molecules using a parylene-matrix chip.
Kim JI; Park JM; Noh JY; Kang MJ; Pyun JC
Rapid Commun Mass Spectrom; 2014 Nov; 28(21):2301-6. PubMed ID: 25279743
[TBL] [Abstract][Full Text] [Related]
5. Newborn screening by matrix-assisted laser desorption/ionization mass spectrometry based on parylene-matrix chip.
Kim JI; Noh JY; Kim M; Park JM; Song HW; Kang MJ; Pyun JC
Anal Biochem; 2017 Aug; 530():31-39. PubMed ID: 28465033
[TBL] [Abstract][Full Text] [Related]
6. A highly sensitive carbapenemase assay using laser desorption/ionization mass spectrometry based on a parylene-matrix chip.
Park JM; Kim JI; Noh JY; Kim M; Kang MJ; Pyun JC
Enzyme Microb Technol; 2017 Sep; 104():56-68. PubMed ID: 28648181
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous analysis of acylcarnitines using MALDI-TOF mass spectrometry based on a parylene matrix chip.
Noh JY; Kim MJ; Yun TG; Kang MJ; Pyun JC
Analyst; 2022 Nov; 147(22):5044-5053. PubMed ID: 36196954
[TBL] [Abstract][Full Text] [Related]
8. Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches.
Silsirivanit A; Sawanyawisuth K; Riggins GJ; Wongkham C
J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):388-96. PubMed ID: 24616382
[TBL] [Abstract][Full Text] [Related]
9. Reduced levels of N'-methyl-2-pyridone-5-carboxamide and lysophosphatidylcholine 16:0 in the serum of patients with intrahepatic cholangiocarcinoma, and the correlation with recurrence-free survival.
Kim KH; Joo J; Park B; Park SJ; Lee WJ; Han SS; Kim TH; Hong EK; Woo SM; Yoo BC
Oncotarget; 2017 Dec; 8(68):112598-112609. PubMed ID: 29348849
[TBL] [Abstract][Full Text] [Related]
10. Highly sensitive bacterial susceptibility test against penicillin using parylene-matrix chip.
Park JM; Kim JI; Song HW; Noh JY; Kang MJ; Pyun JC
Biosens Bioelectron; 2015 Sep; 71():306-312. PubMed ID: 25919811
[TBL] [Abstract][Full Text] [Related]
11. Hypersensitive antibiotic susceptibility test based on a β-lactamase assay with a parylene-matrix chip.
Park JM; Kim JI; Noh JY; Kim M; Kang MJ; Pyun JC
Enzyme Microb Technol; 2017 Feb; 97():90-96. PubMed ID: 28010777
[TBL] [Abstract][Full Text] [Related]
12. A fast method for the determination of the PC/LPC ratio in intact serum by MALDI-TOF MS: an easy-to-follow lipid biomarker of inflammation.
Angelini R; Vortmeier G; Corcelli A; Fuchs B
Chem Phys Lipids; 2014 Oct; 183():169-75. PubMed ID: 25016154
[TBL] [Abstract][Full Text] [Related]
13. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC
Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
[TBL] [Abstract][Full Text] [Related]
14. High level of phosphatidylcholines/lysophosphatidylcholine ratio in urine is associated with prostate cancer.
Li X; Nakayama K; Goto T; Kimura H; Akamatsu S; Hayashi Y; Fujita K; Kobayashi T; Shimizu K; Nonomura N; Ogawa O; Inoue T
Cancer Sci; 2021 Oct; 112(10):4292-4302. PubMed ID: 34328656
[TBL] [Abstract][Full Text] [Related]
15. Profiling of Serum Metabolites Using MALDI-TOF and Triple-TOF Mass Spectrometry to Develop a Screen for Ovarian Cancer.
Lee JH; Kim YH; Kim KH; Cho JY; Woo SM; Yoo BC; Kim SC
Cancer Res Treat; 2018 Jul; 50(3):883-893. PubMed ID: 28934848
[TBL] [Abstract][Full Text] [Related]
16. Parameters affecting the accuracy of the MALDI-TOF MS determination of the phosphatidylcholine/lysophosphatidylcholine (PC/LPC) ratio as potential marker of spermatozoa quality.
Bresler K; Pyttel S; Paasch U; Schiller J
Chem Phys Lipids; 2011 Oct; 164(7):696-702. PubMed ID: 21827741
[TBL] [Abstract][Full Text] [Related]
17. Determination of the Phosphatidylcholine/Lysophosphatidylcholine Ratio in Intact Serum by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry with Prior Enzymatic Albumin Digestion.
Ditz T; Fuchs B
Lipids; 2018 Oct; 53(10):971-977. PubMed ID: 30485452
[TBL] [Abstract][Full Text] [Related]
18. Thin-layer chromatography/matrix-assisted laser desorption/ionisation mass spectrometry and matrix-assisted laser desorption/ionisation mass spectrometry imaging for the analysis of phospholipids in LS174T colorectal adenocarcinoma xenografts treated with the vascular disrupting agent DMXAA.
Batubara A; Carolan VA; Loadman PM; Sutton C; Shnyder SD; Clench MR
Rapid Commun Mass Spectrom; 2015 Jul; 29(14):1288-96. PubMed ID: 26405790
[TBL] [Abstract][Full Text] [Related]
19. Surface preparation strategies for improved parallelization and reproducible MALDI-TOF MS ligand binding assays.
Roth MJ; Maresh EM; Plymire DA; Zhang J; Corbett JR; Robbins R; Patrie SM
ACS Appl Mater Interfaces; 2013 Jan; 5(1):6-10. PubMed ID: 23249094
[TBL] [Abstract][Full Text] [Related]
20. Black phosphorus-assisted laser desorption ionization mass spectrometry for the determination of low-molecular-weight compounds in biofluids.
He XM; Ding J; Yu L; Hussain D; Feng YQ
Anal Bioanal Chem; 2016 Sep; 408(22):6223-33. PubMed ID: 27382971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
